Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hiroyuki Mano

Showing results (191-200 of 263) with videos related to

Pageof 27
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 4, 2018
Fusion Kinases Identified by Genomic Analyses of Sporadic Microsatellite Instability-High Colorectal CancersKazuhito Sato, Masahito Kawazu, Yoko Yamamoto, et al.
Nucleic Acids Research|September 16, 2006
Mouse microRNA profiles determined with a new and sensitive cloning methodShuji Takada, Eugene Berezikov, Yoshihiro Yamashita, et al.
Cancer Science|September 29, 2009
Identification of transforming activity of free fatty acid receptor 2 by retroviral expression screeningHisashi Hatanaka, Mamiko Tsukui, Shuji Takada, et al.
Nature Biomedical Engineering|March 30, 2021
Rapid reprogramming of tumour cells into cancer stem cells on double-network hydrogelsJun Suzuka, Masumi Tsuda, Lei Wang, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 6, 2013
Transforming mutations of RAC guanosine triphosphatases in human cancersMasahito Kawazu, Toshihide Ueno, Kenji Kontani, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 11, 2023
Phase II Trial of Nivolumab in Metastatic Rare Cancer with dMMR or MSI-H and Relation with Immune Phenotypic Analysis (the ROCK Trial)Hitomi S Okuma, Keisuke Watanabe, Kenji Tsuchihashi, et al.
Oncogene|August 2, 2024
GLI1 confers resistance to PARP inhibitors by activating the DNA damage repair pathwayHiroshi Ikeuchi, Yusuke Matsuno, Rika Kusumoto-Matsuo, et al.
Anticancer Research|May 27, 2026
Genomic Profiling of Cancerous Areas, Dysplasia, and Background Mucosa in Ulcerative Colitis-associated Colorectal CancerKaoruko Funakoshi, Kazuhito Sasaki, Keisuke Hata, et al.
Clinical Orthopaedics and Related Research|June 23, 2020
Assessment of Predictive Biomarkers of the Response to Pazopanib Based on an Integrative Analysis of High-grade Soft-tissue Sarcomas: Analysis of a Tumor Sample from a Responder and Patients with Other Soft-tissue SarcomasYoshiyuki Suehara, Shinji Kohsaka, Shigeo Yamaguchi, et al.
Leukemia|January 31, 2019
A germline HLTF mutation in familial MDS induces DNA damage accumulation through impaired PCNA polyubiquitinationKensuke Takaoka, Masahito Kawazu, Junji Koya, et al.
Pageof 27

Showing results (191-200 of 263) with videos related to

Sort By:
Pageof 27
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 4, 2018
Fusion Kinases Identified by Genomic Analyses of Sporadic Microsatellite Instability-High Colorectal CancersKazuhito Sato, Masahito Kawazu, Yoko Yamamoto, et al.
Nucleic Acids Research|September 16, 2006
Mouse microRNA profiles determined with a new and sensitive cloning methodShuji Takada, Eugene Berezikov, Yoshihiro Yamashita, et al.
Cancer Science|September 29, 2009
Identification of transforming activity of free fatty acid receptor 2 by retroviral expression screeningHisashi Hatanaka, Mamiko Tsukui, Shuji Takada, et al.
Nature Biomedical Engineering|March 30, 2021
Rapid reprogramming of tumour cells into cancer stem cells on double-network hydrogelsJun Suzuka, Masumi Tsuda, Lei Wang, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 6, 2013
Transforming mutations of RAC guanosine triphosphatases in human cancersMasahito Kawazu, Toshihide Ueno, Kenji Kontani, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 11, 2023
Phase II Trial of Nivolumab in Metastatic Rare Cancer with dMMR or MSI-H and Relation with Immune Phenotypic Analysis (the ROCK Trial)Hitomi S Okuma, Keisuke Watanabe, Kenji Tsuchihashi, et al.
Oncogene|August 2, 2024
GLI1 confers resistance to PARP inhibitors by activating the DNA damage repair pathwayHiroshi Ikeuchi, Yusuke Matsuno, Rika Kusumoto-Matsuo, et al.
Anticancer Research|May 27, 2026
Genomic Profiling of Cancerous Areas, Dysplasia, and Background Mucosa in Ulcerative Colitis-associated Colorectal CancerKaoruko Funakoshi, Kazuhito Sasaki, Keisuke Hata, et al.
Clinical Orthopaedics and Related Research|June 23, 2020
Assessment of Predictive Biomarkers of the Response to Pazopanib Based on an Integrative Analysis of High-grade Soft-tissue Sarcomas: Analysis of a Tumor Sample from a Responder and Patients with Other Soft-tissue SarcomasYoshiyuki Suehara, Shinji Kohsaka, Shigeo Yamaguchi, et al.
Leukemia|January 31, 2019
A germline HLTF mutation in familial MDS induces DNA damage accumulation through impaired PCNA polyubiquitinationKensuke Takaoka, Masahito Kawazu, Junji Koya, et al.
Pageof 27